IRD 8-K 2026-09-11

Opus Genetics, Inc. (IRD) 8-K dated 2026-09-11 — accession 0001140361-26-036277. This URL is the filing, not the IRD hub.

Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.

Opus Genetics, Inc. filed a 8-K on 2026-09-11. Accession 0001140361-26-036277.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported IRD revenue for 2025-12-31 was $14.2M. Net income was -$49.6M. Revenue was up 29.1% from 2024-12-31 to 2025-12-31. IRD currently screens at market cap $35.7M.

Not investment advice. The IRD SEC hub lists recent forms. The stock page is the research view.